A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy
Contemporary Clinical Trials · 2023-04 · 127 · 107113
DOI: 10.1016/j.cct.2023.107113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2023-04. Verfasst von Dapeng Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Statistics, East China Normal University, Shanghai, China. Hauptthemen laut MEDLINE: Models, Statistical, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
For molecularly targeted therapy and immunotherapy, the targeted dose in the early phase clinical trial has been shifted from the maximum tolerated dose for the cytotoxic drug to the optimal biological dose where both toxicity and efficacy are considered. In this paper, we consider the situation that the responses of toxicity and efficacy are mixed in binary and continuous types, respectively, where the continuous endpoint bears more magnitude information than the binary endpoint after dichotomization. We propose combining two model-based designs to sequentially identify the most efficacious and tolerably safe dose. The employed designs both take the dose level information into account to achieve high estimation efficiency. We demonstrate the superiority of the proposed method to some existing methods by simulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Statistics, East China Normal University, Shanghai, China.
- School of Statistics, East China Normal University, Shanghai, China; Key Laboratory of Advanced Theory and Application in Statistics and Data Science - MOE, East China Normal University, Shanghai, China. Electronic addr…
Zitieren
APA
Zhang, D., & Xu, J. (2023). A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy. Contemporary Clinical Trials, 127, 107113. https://doi.org/10.1016/j.cct.2023.107113
Vancouver
Zhang D, Xu J. A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy. Contemporary Clinical Trials. 2023;127:107113. doi:10.1016/j.cct.2023.107113
BibTeX
@article{Zhang2023,
author = {Zhang, Dapeng and Xu, Jin},
title = {A Bayesian design for finding optimal biological dose with mixed types of responses of toxicity and efficacy},
journal = {Contemporary Clinical Trials},
year = {2023},
volume = {127},
pages = {107113},
doi = {10.1016/j.cct.2023.107113}
}
EUVIMED